Granted Patent
B2
US 7,420,055 · App. 10/846,241 · Granted Sep 2, 2008
Aryl sulfonamides
Assignee:
Chemocentryx, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists.
Claims (7)
1. A compound of the formula:
2. A compound of the formula:
3. A compound of the formula:
4. A compound of the formula:
5. A compound of the formula:
6. A compound of the formula:
7. A compound of the formula:
Assignments (3)
ASSIGNEE CHANGE OF ADDRESS
Recorded Jun 27, 2023
From: CHEMOCENTRYX, INC.
To: CHEMOCENTRYX, INC.
Reel/Frame 064144/0685 →
RECORD TO CORRECT THE SECOND AND FIFTH ASSIGNOR NAMES ON ASSIGNMENT DOCUMENT PER RECORDED ON REEL/FRAME 015944/0061.
Recorded Jul 8, 2005
From: UNGASHE, SOLOMON; WRIGHT, JOHN J.; PENNELL, ANDREW; WEI, ZHENG; MELIKIAN, ANITA
To: CHEMOCENTRYX, INC.
Reel/Frame 016505/0640 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Nov 1, 2004
From: UNGASHE, SOLOMON; WRIGHT, J.J.; PENNELL, ANDREW; WEI, ZHENG; MELIKAN, ANITA
To: CHEMOCENTRYX
Reel/Frame 015944/0061 →
Continuity (3)
Provisional Application
6042767000
· Nov 18, 2002